Skip to content

Clinical trials

Completed Leukemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Status: Completed Clear all

1,398 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200077
200150
200258
200360
200467
200597
200675
200776
200891
200970
201060
201165
201262
201341
201426
201542
201626
201721
201813
201917
202013
202113
202213
20237
20245
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,398

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center153
Children's Oncology Group92
Memorial Sloan Kettering Cancer Center71
National Cancer Institute (NCI)55
Fred Hutchinson Cancer Center52
Alliance for Clinical Trials in Oncology29
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins27
SWOG Cancer Research Network25
Roswell Park Cancer Institute21
Novartis Pharmaceuticals20

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia1,398
Leukemia, Myeloid, Acute471
Lymphoma440
Precursor Cell Lymphoblastic Leukemia-Lymphoma404
Myelodysplastic Syndromes372
Leukemia, Lymphocytic, Chronic, B-Cell342
Lymphoma, Non-Hodgkin233
Multiple Myeloma196
Hodgkin Disease189
Burkitt Lymphoma177

Trials

Showing 26 to 50 of 1,398. Each trial links to its page on Pharma Observatory.

1,298 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.